Drug Database · Clinicians

Aceclofenac

Brands (17) Aceclo-X, Aceclomed, Acedocare…Show all

Non-steroidal anti-inflammatory drug /NSAID ( acetic acid derivative and related substance); Non-steroidal anti-inflammatory drug / NSAID (acetic derivative and related substance); and others PH FDA category

Contraindicated in severe CKDRx · Prescription drug17 PH products Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Contraindications

  • Hypersensitivity to aceclofenac or excipients
  • Aspirin- or NSAID-induced asthma, bronchospasm, rhinitis or urticaria
  • Active bleeding or bleeding disorders
  • Previous NSAID-related gastrointestinal bleeding or perforation
  • Active or recurrent peptic ulcer or hemorrhage
  • Established heart failure (NYHA class II–IV), ischemic heart disease, peripheral arterial disease or cerebrovascular disease
  • Severe hepatic or kidney impairment
  • Third trimester of pregnancy
renalcarematters.com, reviewed

Dosing: Adult

  • Pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis: 100 mg twice daily (morning and evening); maximum 200 mg/day
  • Mild to moderate hepatic impairment: Start at 100 mg/day
renalcarematters.com, reviewed

Dosing: Altered kidney function

Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID) partly converted to diclofenac; about two-thirds of a dose leaves in urine as metabolites. NSAIDs can precipitate kidney failure in at-risk patients. The European label needs no dose change in mild kidney impairment (with caution), asks for the lowest dose and regular kidney monitoring in mild to moderate impairment, and contraindicates it in severe impairment. It has no US FDA label.

Kidney function measure: The SmPC grades kidney impairment as mild, moderate or severe without numbers; bands map 'severe' to creatinine clearance (CrCl) <30 mL/min.

Show full dosing details
CrCl ≥60 mL/min
Usual: 100 mg twice daily; maximum 200 mg/day (SmPC). Mild impairment: no dose change but caution.
CrCl 30–59 mL/min
Mild to moderate impairment: lowest effective dose with surveillance and regular kidney function checks (SmPC). Avoid with volume depletion or diuretics where possible. Short courses only; hold during intercurrent illness or volume depletion (sick-day rule; KDIGO 2024).
CrCl 15–29 mL/min
Severe kidney impairment: contraindicated (SmPC; no numeric threshold). Our mapping of 'severe' to CrCl <30 is a judgment.
CrCl <15 mL/min (not on dialysis)
Severe kidney impairment: contraindicated (SmPC; no numeric threshold). Our mapping of 'severe' to CrCl <30 is a judgment.
Hemodialysis (intermittent)
Contraindicated (severe kidney impairment; SmPC).
Peritoneal dialysis
Contraindicated (severe kidney impairment; SmPC). NSAIDs hasten loss of residual kidney function.
CRRT
Contraindicated; NSAIDs worsen acute kidney injury.
  • Dialyzable? Not stated (over 99.7% protein-bound).
  • Monitoring Kidney function regularly in mild to moderate impairment, heart failure, liver disease, diuretic use, after major surgery and in older adults; blood pressure; potassium with potassium-sparing diuretics; gastrointestinal bleeding (SmPC 4.4). Check creatinine and potassium within 1–2 weeks of starting in CKD or with an ACE inhibitor, ARB, mineralocorticoid receptor antagonist (MRA) or diuretic; avoid the NSAID + ACE inhibitor/ARB + diuretic ("triple whammy") combination and long-term use in CKD.
Children (kidney dosing)
eGFR ≥60
Not established in children; kidney dosing not applicable.
eGFR 30–59
Not established in children; kidney dosing not applicable.
eGFR 15–29
Not established in children; kidney dosing not applicable.
eGFR <15 (not on dialysis)
Not established in children; kidney dosing not applicable.
Hemodialysis (intermittent)
Not established in children; kidney dosing not applicable.
Peritoneal dialysis
Not established in children; kidney dosing not applicable.
CRRT
Not established in children; kidney dosing not applicable.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: MPA (Sweden) product information (March 24, 2023). This generic has no US FDA label.

Dosing: Pediatric

Approved ages
Not established in children and adolescents (SmPC).
Usual dose
Not established.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Film-coated tablet: 100 mg
  • Controlled-release tablet: 200 mg
  • Softgel capsule: 100 mg
  • Sustained-release tablet: 200 mg
  • Tablet: 100 mg

Registered products in the Philippines

17 products registered with the Food and Drug Administration (FDA) Philippines list Aceclofenac as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products17
Philippine FDA-registered products for Aceclofenac
Package insert
Aceclo-XAceclofenac
100mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Teramedix Pharma Trading Inc.
DR-XY47814
Mar 14, 2027
AceclomedAceclofenac
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Acme Formulation Pvt. Ltd.India
Medinova Pharmaceutical Inc.
DRP-12160
Jun 24, 2027
AcedocareAceclofenac
100 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 100's)
Rx
Mediwin PharmaceuticalsIndia
Cyden Medicale Trading Inc.Importer: Ambica International Corporation
DRP-4678-02
Sep 6, 2028
ACF-100Aceclofenac
100 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-4678
Sep 6, 2028
AfenaxAceclofenac
100 mg Film-Coated TabletClear PVDC/ Alu Blister Pack x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Solvang Pharmaceuticals, Inc.
DRP-9980
Feb 18, 2028
AirtalAceclofenac
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 20's, 40's, 50's and 100's)
Rx
Industrias Farmaceuticas Almirall, S.A.Spain
Pacific Healthcare Philippines, Inc.
DR-XY37620
Mar 4, 2031
CeclofamAceclofenac
100mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) (Box of 30’s)
Rx
ACME Formulations Pvt. Ltd.India
JJJ Pharmaceutical Marketing Inc.Importer: Medinova Pharmaceutical Inc.
DRP-12160-01
Jun 24, 2027
ClanzaAceclofenac
100 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Korea United Pharm. Inc.Republic of Korea
One Pharma Marketing Inc.
DR-XY30590
Mar 25, 2031
Clanza CRAceclofenac
200 mg Controlled-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Korea United Pharm. Inc.Republic of Korea
One Pharma Marketing Inc.
DR-XY39980
Sep 1, 2031
Clanza SAceclofenac
100 mg Softgel CapsuleAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Korea United Pharm. Inc.Republic Of Korea
One Pharma Marketing Inc.
DR-XY34671
Mar 26, 2032
DiclotolAceclofenac
100 mg Film-Coated TabletAlu/Alu Blister Pack X 10'S (Box of 50's); Physician's Sample Alu/Alu Blister Pack X 1'S (Box of 1's )
Rx
Kusum Healthcare Private LimitedIndia
Kusum Healthcare Private Limited Branch Office
DR-XY42297
Mar 6, 2031
DolowinAceclofenac
100mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's and 100's
Rx
MICRO LABS LIMITEDIndia
BROWN & BURK PHILIPPINES, INC.
DR-XY41396
Nov 23, 2027
Dolowin SRAceclofenac
200 mg Sustained Release TabletAlu/Clear PVC Blister Pack x 10's (Box of 50's)
Rx
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY41012
Jul 9, 2027
FenaxinAceclofenac
100 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Mediwin PharmaceuticalsIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-4678-01
Sep 6, 2028
SofenacAceclofenac
100 mg Softgel CapsulePVC/Aluminum Blister Pack x 10's (Box of 30's and 100's)
Rx
Phil Inter Pharma Co., LtdVietnam
Lealmeds Pharmaceutical Inc.
DR-XY43694
Sep 3, 2029
ZerodolAceclofenac
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
IPCA Laboratories Ltd.India
Blue Global (FZE)
DRP-9902
Nov 27, 2029
Zerodol-CRAceclofenac
200 mg Controlled-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Ipca Laboratories LimitedIndia
Importer: Blue Global (FZE)
DRP-12486
Feb 5, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Drug interactions

Drug or classSeverityEffectWhat to do
Other NSAIDs, COX-2 inhibitorsAvoidMore gastrointestinal bleeding.Do not combine.
High-dose methotrexateAvoidMethotrexate toxicity.Avoid.
Lithium, digoxinAdjust or monitorHigher levels.Avoid unless levels are monitored frequently.
ACE inhibitors or ARBs plus a diuretic ("triple whammy")AvoidAcute kidney injury, hyperkalemia.Avoid the triple combination; if unavoidable, hydrate and check creatinine and potassium within 1 week.
ACE inhibitors, ARBs, mineralocorticoid receptor antagonists or diuretics (single agent)Adjust or monitorAcute kidney injury; hyperkalemia in CKD.Hydrate; monitor creatinine and potassium.
Cyclosporine, tacrolimus, low-dose methotrexateAdjust or monitorKidney toxicity.Monitor kidney function.
Warfarin, antiplatelets, corticosteroids, SSRIsAdjust or monitorMore gastrointestinal bleeding.Use with caution.
Potassium-sparing diureticsAdjust or monitorHyperkalemia.Monitor potassium.
CYP2C9 substrates or inhibitors (phenytoin, amiodarone, miconazole)MinorPossible interaction via CYP2C9.Monitor.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed

Adverse reactions

Common

  • Dyspepsia, abdominal pain, nausea, diarrhea
  • Dizziness

Serious

  • Gastrointestinal bleeding, ulceration, perforation
  • Myocardial infarction and stroke (diclofenac-like risk)
  • Kidney failure, nephrotic syndrome, interstitial nephritis
  • Hepatitis
  • Anaphylaxis; Stevens-Johnson syndrome, toxic epidermal necrolysis
renalcarematters.com, reviewed

Monitoring parameters

  • Kidney function regularly in mild to moderate impairment, heart failure, liver disease, diuretic use, after major surgery and in older adults; blood pressure; potassium with potassium-sparing diuretics; gastrointestinal bleeding (SmPC 4.4). Check creatinine and potassium within 1–2 weeks of starting in CKD or with an ACE inhibitor, ARB, mineralocorticoid receptor antagonist (MRA) or diuretic; avoid the NSAID + ACE inhibitor/ARB + diuretic ("triple whammy") combination and long-term use in CKD. Kidney
  • Creatinine and potassium within 1–2 weeks of starting in CKD or with an ACE inhibitor, ARB, mineralocorticoid receptor antagonist or diuretic; avoid long-term use in CKD
  • Kidney function regularly in CKD
  • Blood pressure
  • Gastrointestinal bleeding
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

BioavailabilityAlmost 100%
Time to peak1.25 to 3 hours
Half-life4 to 4.3 hours
Half-life in kidney failure (ESKD) kidneyNo clinically significant change in mild to moderate impairment (single dose); severe not studied
Volume of distributionAbout 30 L
Protein bindingOver 99.7%
Metabolism (CYP, transporters)Mainly CYP2C9 to 4'-OH-aceclofenac; diclofenac formed
Active metabolitesDiclofenac (minor)
Renal excretion kidneyAbout two-thirds in urine as metabolites; 1% unchanged
Dialyzability kidneyNot stated
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Swedish Medical Products Agency. Barcan 100 mg film-coated tablets SmPC (English) [MPA (Sweden) product information, March 24, 2023; no US FDA label]. https://docetp.mpa.se/LMF/Barcan%20film-coated%20tablet%20ENG%20SmPC_09001bee807a07bc.pdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. Almirall, S.A. (2023). Barcan 100 mg film-coated tablets (aceclofenac) [Summary of product characteristics, English; revised March 24, 2023]. Swedish Medical Products Agency (Läkemedelsverket). https://docetp.mpa.se/LMF/Barcan%20film-coated%20tablet%20ENG%20SmPC_09001bee807a07bc.pdf
  4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .